Musaffa Logo
J
JLens 500 Jewish Advocacy U.S. ETF TOV

TOV Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, JLens 500 Jewish Advocacy U.S. ETF is classified as not halal.

NOT HALAL

Is JLens 500 Jewish Advocacy U.S. ETF Halal?

Shariah Compliance Analysis of TOV ETF

US Equity Large Cap

No. As of September 2026, JLens 500 Jewish Advocacy U.S. ETF (TOV) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. JLens 500 Jewish Advocacy U.S. ETF does not pass Musaffa's business and financial screening criteria.

JLens 500 Jewish Advocacy U.S. ETF (TOV) Chart

Key Statistics of JLens 500 Jewish Advocacy U.S. ETF (TOV)

Today's Open

-

AUM

-

Avg. Volume

-

Expense Ratio

-

P/E Ratio

-

P/B Ratio

-

FAQ's for JLens 500 Jewish Advocacy U.S. ETF (TOV)

  • As of September 2026, JLens 500 Jewish Advocacy U.S. ETF TOV is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes JLens 500 Jewish Advocacy U.S. ETF using these criteria to determine its compliance status.
  • The Shariah compliance status of JLens 500 Jewish Advocacy U.S. ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
  • Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
  • You can check the latest Shariah compliance status of JLens 500 Jewish Advocacy U.S. ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.